Literature DB >> 24977379

Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters.

Jacqueline Jonklaas1, Kenneth D Burman, Hong Wang, Keith R Latham.   

Abstract

BACKGROUND: As changes in thyroid stimulating hormone (TSH), thyroid hormones, and vital signs after administration of a single dose of liothyronine have typically only been documented for 24 hours, we documented these parameters more than 96 hours.
METHODS: Blood samples were obtained for 4 days after administration of 50-mcg liothyronine to 12 healthy euthyroid participants. Concentrations of total and free triiodothyronine, free and total thyroxine, and TSH were measured. Vital signs were documented.
RESULTS: Triiodothyronine concentrations peaked at 2.5 hours after liothyronine administration. Heart rate (HR) increased by 5 hours after liothyronine administration, subsequently reaching a value higher than baseline (P = 0.009). Suppression of TSH concentrations began at 2 hours. The nadir TSH value at 12 hours was significantly different from baseline (P < 0.001) and remained lower than the baseline value for 2-3 days.
CONCLUSIONS: A single dose of liothyronine has both short-term and long-term effects. There is clearly a different lag time between the serum concentrations of triiodothyronine and its effects on the heart and pituitary, respectively. The increase in serum triiodothyronine concentration occurred within hours and was then followed by an increase in HR. The increased HR was transient and was followed by a reduction in TSH concentration. The suppression of TSH was delayed but was more sustained. Thus, sustained TSH reduction beyond 24 hours was achieved by a single dose of liothyronine that produced only brief increases in serum triiodothyronine levels and transient increases in HR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24977379      PMCID: PMC5167556          DOI: 10.1097/FTD.0000000000000113

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  16 in total

1.  Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Authors:  Francesco S Celi; Marina Zemskova; Joyce D Linderman; Sheila Smith; Bart Drinkard; Vandana Sachdev; Monica C Skarulis; Merel Kozlosky; Gyorgy Csako; Rene Costello; Frank Pucino
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

2.  Part-of-the-day hypertriiodothyroninemia caused by desiccated thyroid.

Authors:  A Lev-Ran
Journal:  JAMA       Date:  1983-11-25       Impact factor: 56.272

3.  Circadian and pulsatile TSH secretion under physiological and pathophysiological conditions.

Authors:  G Brabant; K Prank; U Ranft; P Bergmann; T Schuermeyer; R D Hesch; A von zur Mühlen
Journal:  Horm Metab Res Suppl       Date:  1990

4.  Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.

Authors:  S Ueda; J Takamatsu; S Fukata; K Tanaka; N Shimizu; S Sakata; T Yamaji; K Kuma; N Ohsawa
Journal:  Thyroid       Date:  1996-12       Impact factor: 6.568

Review 5.  Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism.

Authors:  Maria Izabel Chiamolera; Fredric E Wondisford
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

6.  Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.

Authors:  P Saravanan; H Siddique; D J Simmons; R Greenwood; C M Dayan
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-04       Impact factor: 2.949

7.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.

Authors:  Marisa Eisenberg; Mary Samuels; Joseph J DiStefano
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

9.  A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich.

Authors:  P A Mackowiak; S S Wasserman; M M Levine
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

10.  Multiphasic thyrotropin responses to thyroid hormone administration in man.

Authors:  C A Spencer; J S LoPresti; J T Nicoloff; R Dlott; D Schwarzbein
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

View more
  16 in total

1.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

2.  Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans.

Authors:  Alexandra M Dumitrescu; Erin C Hanlon; Marilyn Arosemena; Olga Duchon; Matthew Ettleson; Mihai Giurcanu; Antonio C Bianco
Journal:  Thyroid       Date:  2021-12-31       Impact factor: 6.568

3.  Optimal Thyroid Hormone Replacement.

Authors:  Jacqueline Jonklaas
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 25.261

4.  Circulating Thyroid Hormone Profile in Response to a Triiodothyronine Challenge in Familial Longevity.

Authors:  Ana Zutinic; Gerard J Blauw; Hanno Pijl; Bart E Ballieux; Rudi G J Westendorp; Ferdinand Roelfsema; Diana van Heemst
Journal:  J Endocr Soc       Date:  2020-08-20

5.  Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.

Authors:  Jacqueline Jonklaas; Kenneth D Burman
Journal:  Thyroid       Date:  2016-04-28       Impact factor: 6.568

6.  High Resolution Free Triiodothyronine-Thyrotropin (FT3-TSH) Responses to a Single Oral Dose of Liothyronine in Humans: Evidence of Distinct Inter-Individual Differences Unraveled Using an Electrical Network Model.

Authors:  Simon L Goede; Keith R Latham; Melvin Khee-Shing Leow; Jacqueline Jonklaas
Journal:  J Biol Syst       Date:  2017-02-24       Impact factor: 1.000

Review 7.  Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.

Authors:  Thaer Idrees; Scott Palmer; Rui M B Maciel; Antonio C Bianco
Journal:  Thyroid       Date:  2020-05-12       Impact factor: 6.568

Review 8.  T4 + T3 combination therapy: any progress?

Authors:  Wilmar M Wiersinga
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

9.  Thyroid Hormone Protects from Fasting-Induced Skeletal Muscle Atrophy by Promoting Metabolic Adaptation.

Authors:  Sarassunta Ucci; Alessandra Renzini; Valentina Russi; Claudia Mangialardo; Ilenia Cammarata; Giorgia Cavioli; Maria Giulia Santaguida; Camilla Virili; Marco Centanni; Sergio Adamo; Viviana Moresi; Cecilia Verga-Falzacappa
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

10.  Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design.

Authors:  Ritu Madan; Francesco S Celi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.